Showing 41 - 60 results of 138,297 for search '(( 1 m decrease ) OR ( 5 ((((fold decrease) OR (point decrease))) OR (a decrease)) ))', query time: 2.13s Refine Results
  1. 41
  2. 42
  3. 43
  4. 44
  5. 45
  6. 46

    A homozygous point mutation in the <i>Mrps34</i> gene causes a decrease in the MRPS34 protein. by Tara R. Richman (713532)

    Published 2015
    “…<p>(A) Schematic showing the location of the mutation in the <i>Mrps34</i> gene, mRNA and protein. …”
  7. 47
  8. 48
  9. 49

    IFN-β mRNA induction but IFN protein decrease in all mammalian cells upon ONNV infection. by Susanne E. Biesold (194461)

    Published 2011
    “…(E) Comparison of mRNA fold-induction of IFN stimulated genes (<i>MxA</i> and <i>ISG56</i>) to secreted IFN protein at time points 0 hpi and 24 hpi. …”
  10. 50
  11. 51

    Genes whose expression was decreased in RASMC subjected to Na<sup>+</sup>,K<sup>+</sup>-ATPase inhibition. by Svetlana V. Koltsova (321381)

    Published 2014
    “…GeneChip expression analysis was performed as described in the Methods section. mRNA content in control cells was taken as 1.00. …”
  12. 52
  13. 53
  14. 54

    Combination metabolic therapy decreases VM-M3 cell proliferation <i>in vitro</i>. by A. M. Poff (752552)

    Published 2015
    “…Cell density was measured with trypan blue hemocytometry to produce a growth curve over 96 hours. <b>(A)</b> Proliferation of VM-M3 cells was inhibited with decreasing glucose concentration and the addition of HBOT. …”
  15. 55
  16. 56
  17. 57

    (R)-albuterol decreases cytokine mRNA levels in activated T cells by Marcela A Ferrada (41716)

    Published 2011
    “…</p><p></p> (R)-albuterol, (S)-albuterol or racemic albuterol (R + S) at a dose (10M) were added to T (EL-4) cells pre-activated with mitogens Concanavalin A (Con A, 5 μg/ml) and phorbol myristate acetate (PMA, 100 ng/ml) (CP). …”
  18. 58

    Eltrombopag markedly decreases levels of ROS in MOLM14 cells. by Anna Kalota (7415)

    Published 2015
    “…B) Graphic presentation of ROS levels measured by flow cytometry in cells treated with E (5 μM) or DPI (25 μM), an inhibitor of NADPH oxidase known to decrease an intracellular level of ROS, or untreated (CTR) cells. …”
  19. 59

    PowerPoint Slides for: Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis by Bushinsky D.A. (3246690)

    Published 2016
    “…<p><b><i>Background:</i></b> Persistent hyperkalemia (serum potassium (K) ≥5.5 mEq/l) is a common condition in hemodialysis (HD) patients, is associated with increased mortality, and treatment options are limited. …”
  20. 60

    Significant decrease of SMAD4 protein in DBA iPSCs. by Jingping Ge (636557)

    Published 2015
    “…A) Slight decrease of mRNA level of <i>SMAD4</i> in the DBA iPSCs with <i>RPS19</i> or <i>RPL5</i> mutations. …”